Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Rare Diseases

Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Neuroleptic Malignant Syndrome[original query]
Lack of association in Japanese patients between neuroleptic malignant syndrome and a debrisoquine 4-hydroxylase genotype with low enzyme activity.
Psychiatric genetics 2000 Sep 10 (3): 145-7.
Kawanishi C, Furuno T, Onishi H, Sugiyama N, Suzuki K, Matsumura T, Ishigami T, Kosaka
Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome.
The American journal of psychiatry 2001 Oct 158 (10): 1714-6.
Suzuki A, Kondo T, Otani K, Mihara K, Yasui-Furukori N, Sano A, Koshiro K, Kaneko
Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene.
Psychiatric genetics 2003 Mar 13 (1): 55-7.
Kishida Ikuko, Kawanishi Chiaki, Furuno Taku, Matsumura Takehiko, Hasegawa Hana, Sugiyama Naoya, Suzuki Kyoko, Yamada Yoshiteru, Kosaka Ken
Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003 Feb 117B (1): 57-60.
Mihara Kazuo, Kondo Tsuyoshi, Suzuki Akihito, Yasui-Furukori Norio, Ono Shingo, Sano Akira, Koshiro Kazuko, Otani Koichi, Kaneko Sun
Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene.
Molecular psychiatry 2004 Mar 9 (3): 293-8.
Kishida I, Kawanishi C, Furuno T, Kato D, Ishigami T, Kosaka K
Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.
European journal of clinical pharmacology 2007 Nov 63 (11): 991-6.
Kato Daiji, Kawanishi Chiaki, Kishida Ikuko, Furuno Taku, Suzuki Kyoko, Onishi Hideki, Hirayasu Yosh
The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome.
Scientific reports 2023 10 13 (1): 18459.
Yoji Kyotani, Jing Zhao, Kiichi Nakahira, Masanori Yoshizu
TOP